管理多药耐药的潘多利亚菌种. :目前的证据和知识差距
Nicholas Geremia1,2, Stefano Di Bella3
1Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale "dell'Angelo", Venice, Italy.
Le infezioni in medicina
|September 11, 2025
概括
潘多雷亚细菌是新兴的多药耐药病原体. 伊米内姆和三甲胺-硫法佐醇表现出活性,为治疗这些困难感染提供了选择.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 潘多雷亚物种是格拉姆阴性,不发酵的细菌,在脆弱的患者中引起感染.
- 这些病原体表现出内在的多药耐药性 (MDR),这给治疗带来了挑战.
研究的目的:
- 审查当前关于潘多利亚菌感染和抗菌素敏感性的知识.
- 为了指导临床医生选择有效的治疗策略的Pandoraea感染.
主要方法:
- 在PubMed/MEDLINE/Google Scholar和专家微生物学文本中进行了全面的文献搜索.
- 对抗微生物耐药性模式和Pandoraea分离物治疗选择的分析.
主要成果:
- 潘多雷亚分离物经常表现出对常见抗生素的耐药性,如β-乳糖类药物,氨基糖化物,诺基诺和聚米辛.
- 由于特定的OXAβ-乳酸酶 (OXA-1152),许多菌株仍然对伊米 (IMP) 敏感,尽管它们对美罗耐药.
- 伊米 (IMP) 和三甲-硫甲 (SXT) 被确定为最有效的药物.
结论:
- 对于Pandoraea感染存在有限的稳健临床数据,突出了知识差距.
- 建议用伊米 (IMP) 和三甲-硫法 (SXT) 作为主要或组合治疗选择.
- 需要进行进一步的研究,以建立基于证据的治疗指南,以治疗Pandoraea感染.
更多相关视频
相关概念视频
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Gene Regulation in Microbial Communities: Quorum Sensing
534
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
534
Antimicrobial Effectiveness
913
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
913
Pneumonia IV: Management
764
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
764
Antibiotic Selection
59.4K
Overview
59.4K


